Liprin β2 inhibitors are a class of compounds that act by modulating the function of the Liprin β2 protein, which is part of the Liprin family involved in intracellular signaling and cytoskeletal dynamics. Liprin proteins, particularly β isoforms, are crucial in organizing cellular scaffolding and influencing the dynamics of actin and microtubules. Liprin β2, in particular, associates with several proteins that coordinate cellular architecture, including synaptic complexes and focal adhesions. By inhibiting Liprin β2, these compounds interfere with protein-protein interactions that are essential for the structural integrity of cells, potentially affecting processes such as cell motility, morphology, and intracellular trafficking.
Chemically, Liprin β2 inhibitors are diverse in structure, ranging from small organic molecules to larger peptides or mimetics that disrupt key interaction domains of the Liprin β2 protein. Some inhibitors are designed to bind specifically to regions of the Liprin β2 protein that are involved in its interaction with other scaffolding or signaling molecules, thus preventing these interactions from taking place. Other inhibitors may target allosteric sites, altering the overall conformation of the protein and hindering its functional roles. The molecular interactions involved in Liprin β2 inhibition are complex and typically require precise structural features to ensure selectivity and potency. This selectivity is critical for studying the specific biochemical pathways regulated by Liprin β2 in a controlled, non-clinical environment, making these inhibitors valuable tools in the exploration of cellular organization and signal transduction pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor that disrupts the PI3K/Akt pathway. This can have indirect effects on proteins that are downstream or associated with this pathway, including Liprin β2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Another MEK inhibitor targeting the ERK/MAPK pathway, potentially influencing proteins associated with this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor. By inhibiting the PI3K/Akt pathway, it can indirectly affect downstream or associated proteins like Liprin β2. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor. Given Liprin β2's involvement in adhesion, disrupting ROCK can indirectly modulate its associated proteins. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor which can influence the JNK pathway, indirectly affecting associated proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor. By affecting the p38 pathway, it can have downstream effects on associated proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor which affects the mTOR signaling pathway, potentially influencing associated proteins. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB pathway inhibitor. By influencing this pathway, it might indirectly modulate associated or downstream proteins. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
CaMKII inhibitor affecting calcium signaling, which could indirectly modulate proteins associated with this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor. By influencing the Src pathway, it might indirectly affect associated proteins. |